Abstract
Objective
To describe radiographic evidence of radiation pneumonitis (rRP) and fibrosis (rRF) and determine what dosimetric parameters correlate with rRP and rRF after stereotactic ablative radiation therapy (SABR) to the lung.
Methods
Ninety-eight follow-up computed tomography (CT) scans from 32 patients treated by SABR were retrospectively reviewed for CT appearance of rRP and rRF determined by the Ikezoe (≤6 months) and Koenig (≥7 months) systems. The dosimetric correlations for rRP, rRF, and fibrotic volume were analyzed.
Results
There was a 55 % incidence of rRP and 59 % incidence of rRF with a median follow-up of 10 months. Only the low-dose parameters V 2.5, V 5, V 7, and V 10 (the volume of lung receiving more than 2.5, 5, 7, and 10 Gy of radiation, respectively) were correlated to the development of rRP (p < 0.05). No parameter correlated with rRF, but V 5, V 7, and V 10 trended toward significance. The absolute fibrotic volume was correlated with the planning target volume (p = 0.01) and V 7 (p = 0.02).
Conclusion
The development of rRP and the fibrotic volume after SABR was correlated with the volume of lung that received lower doses of radiation.
Similar content being viewed by others
References
Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O’Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC (2010) Non-small cell lung cancer. J Natl Comp Cancer Network: JNCCN 8(7):740–801
Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R (2009) Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75(3):677–682. doi:10.1016/j.ijrobp.2008.11.042
Linda A, Trovo M, Bradley JD (2011) Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur J Radiol 79(1):147–154. doi:10.1016/j.ejrad.2009.10.029
Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69(1):77–85. doi:10.1016/j.lungcan.2009.09.006
Ikezoe J, Takashima S, Morimoto S, Kadowaki K, Takeuchi N, Yamamoto T, Nakanishi K, Isaza M, Arisawa J, Ikeda H, et al. (1988) CT appearance of acute radiation-induced injury in the lung. AJR Am J Roentgenol 150(4):765–770
Koenig TR, Munden RF, Erasmus JJ, Sabloff BS, Gladish GW, Komaki R, Stevens CW (2002) Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 178(6):1383–1388
Guckenberger M, Heilman K, Wulf J, Mueller G, Beckmann G, Flentje M (2007) Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 85(3):435–442. doi:10.1016/j.radonc.2007.10.044
Bradley J (2007) Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol 2(7 Suppl 3):S118–S124. doi:10.1097/JTO.0b013e318074e50c
Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S (2011) Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 6(7):1221–1228. doi:10.1097/JTO.0b013e318219aac5
Kyas I, Hof H, Debus J, Schlegel W, Karger CP (2007) Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67(3):768–774. doi:10.1016/j.ijrobp.2006.08.066
Guckenberger M, Baier K, Polat B, Richter A, Krieger T, Wilbert J, Mueller G, Flentje M (2010) Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 97(1):65–70. doi:10.1016/j.radonc.2010.04.027
Palma DA, van Sornsen de Koste J, Verbakel WF, Vincent A, Senan S (2010) Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.07.025
Prendergast BM, Bonner JA, Popple RA, Spencer SA, Fiveash JB, Keene KS, Cerfolio RJ, Minnich DJ, Dobelbower MC (2011) Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy. J Med Imaging Radiat Oncol 55(1):90–96. doi:10.1111/j.1754-9485.2010.02234.x
Aoki T, Nagata Y, Negoro Y, Takayama K, Mizowaki T, Kokubo M, Oya N, Mitsumori M, Hiraoka M (2004) Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 230(1):101–108. doi:10.1148/radiol.2301021226
Vinogradskiy Y, Diot Q, Kavanagh B, Schefter T, Gaspar L, Miften M (2013) Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy. Med Phys 40(8):081712. doi:10.1118/1.4813916
Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK (2003) Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55(3):724–735
Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC (2005) Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63(3):672–682. doi:10.1016/j.ijrobp.2005.03.026
Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B (2005) Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61(2):318–328. doi:10.1016/j.ijrobp.2004.06.260
Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M (2012) Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys 84(4):1024–1030. doi:10.1016/j.ijrobp.2011.11.080
Kimura T, Matsuura K, Murakami Y, Hashimoto Y, Kenjo M, Kaneyasu Y, Wadasaki K, Hirokawa Y, Ito K, Okawa M (2006) CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 66(2):483–491. doi:10.1016/j.ijrobp.2006.05.008
Ghobadi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S, Langendijk JA, Coppes RP, van Luijk P (2010) Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 76(2):548–556. doi:10.1016/j.ijrobp.2009.08.058
Chi A, Wen S, Liao Z, Fowler J, Xu J, Nguyen NP, Welsh JS, Komaki R (2013) What would be the most appropriate alpha/beta ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer. BioMed Res Int 2013:391021. doi:10.1155/2013/391021
Guckenberger M, Klement RJ, Allgauer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 109(1):13–20. doi:10.1016/j.radonc.2013.09.005
Casamassima F, Masi L, Bonucci I, Polli C, Menichelli C, Gulisano M, Pacini S, Aterini S, Cavedon C (2008) Relevance of biologically equivalent dose values in outcome evaluation of stereotactic radiotherapy for lung nodules. Int J Radiat Oncol Biol Phys 71(1):145–151. doi:10.1016/j.ijrobp.2007.09.036
Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25(8):947–952. doi:10.1200/jco.2006.09.7469
Hof H, Zgoda J, Nill S, Hoess A, Kopp-Schneider A, Herfarth K, Debus J, Plathow C (2010) Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 77(5):1369–1374. doi:10.1016/j.ijrobp.2009.06.082
Komaki R, Travis E, Cox J (2010) The lung, pleura, and thymus. In: Cox J, Ang K (eds) Radiation oncology: rationale, technique. Results. Ninth edn. Mosby, Inc., Philadelphia, PA, p. 425
Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33(1):99–109
Senthi S, Dahele M, van de Ven PM, Slotman BJ, Senan S (2013) Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques. Radiother Oncol 109(1):77–81. doi:10.1016/j.radonc.2013.08.034
Yang M, Zhang L, Bi N, Ji W, Tan W, Zhao L, Yu D, Wu C, Wang L, Lin D (2011) Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 79(5):1402–1407. doi:10.1016/j.ijrobp.2009.12.042
Xiong H, Liao Z, Liu Z, Xu T, Wang Q, Liu H, Komaki R, Gomez D, Wang LE, Wei Q (2013) ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 85(4):1066–1073. doi:10.1016/j.ijrobp.2012.09.024
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
There were no sources of funding for this project.
Conflict of interest statements
John Park does not have any conflict of interests to report.
Saikat Das does not have any conflict of interests to report.
Bruce F. Kimler does not have any conflict of interests to report.
Rajeev Badkul does not have any conflict of interests to report.
Nicole Nolan does not have any conflict of interests to report.
Parvesh Kumar does not have any conflict of interests to report.
Glendon Cox does not have any conflict of interests to report.
Fen Wang does not have any conflict of interests to report.
Ethical standards
This article does not contain any studies with human or animal subjects performed by any of the authors. All patient information was collected on an Institutional Review Board and Human Subjects Committee approved study.
Rights and permissions
About this article
Cite this article
Park, J., Das, S., Kimler, B.F. et al. Radiographic changes in lung of patients treated with stereotactic ablative body radiation therapy: low-dose volumes as the driving force for radiographic change. J Radiat Oncol 5, 265–272 (2016). https://doi.org/10.1007/s13566-016-0254-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-016-0254-7